The FDA’s acceptance for filing of our ANDA for fluticasone furoate, umeclidinium, and vilanterol inhalation powder, a generic version of Trelegy® Ellipta®, is another major milestone in advancing our ...
China NMPA approves GSK’s Trelegy Ellipta for use in adults with uncontrolled asthma: London, UK Saturday, January 24, 2026, 09:00 Hrs [IST] GSK plc announced that China’s Nat ...
Arexvy, GSK's RSV vaccine, is now approved for all adults 18+ in the EU, addressing a significant public health concern. RSV ...
GSK has secured approval in China for Trelegy Ellipta as a maintenance treatment for adults with asthma, adding to its existing indication in COPD and making it the only single inhaler triple therapy ...
ETHealthworld.com brings latest glaxosmithkline pharmaceuticals news, views and updates from all top sources for the Indian Health industry.
Welcome to Fierce Pharma's regulatory tracker for the first half of 2026. On this page, we're recording the regulatory progress of in-market products, including expansions into key geographies and new ...
Game Rant on MSN
How to unlock all of Tifa’s weapons in FF7 Remake
A force of nature, Tifa is an agile fighter who relies on her fists. Here’s where players can find her weapons in Final ...
3hon MSN
Beyond the brand names: Everything you need to know about Ozempic and other GPL-1 medications
Ozempic has become so embedded in global culture that “Ozempic face” was shortlisted for a prominent dictionary’s word of the year in 2025. Ozempic isn’t the only drug that mimics the natural GLP-1 ...
The corticosteroids market is driven by rising chronic diseases like asthma and COPD and innovations in drug delivery systems, enhancing treatment adherence. However, prolonged usage safety concerns ...
Lightly heat the oil in a pan and add all the prepared vegetables. Sauté slowly until they take on a beautiful golden color.
In addition to Bank of America Securities, GlaxoSmithKline also received a Hold from UBS’s Matthew Weston in a report issued on January 21. However, on January 22, J.P. Morgan maintained a Sell rating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results